Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−20.683 EUR
−105.69 M EUR
7.04 M EUR
137.26 M
About Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
"Balanced Biotech Strategy"Trading TNXP requires careful consideration of both the high reward potential and the significant risks involved. Combining technical analysis for short-term trades with a fundamental approach for long-term investments, while employing robust risk management techniques, can help navigate the volatil
TNXP: Tonix Pharmaceuticals, TIME FOR PROFITS?!? ;)What's up my financial amigos and amigas! Hope all is well. Haven't posted in awhile but thought I'd share this: TNXP. Pharmaceutical company with decent history and negative earnings but continued improvement and growth. Working on approval from FDA after successful phase 3 trial of Fibromyalgi
TNXP Squeeze $if we continue to hold our ascending line we going to see a breakout at our current resistant 2.90$+ , and the target level to take profit (2.40$-2.69$-2.90$).
NASDAQ:TNXP
TNXP - Bullish alongside SIGAWe may see some movement on this one in the coming weeks just like SIGA. I have drawn out 2 levels of resistance with interest on my end after a clean break of $2.00. I will be watching for a technical setup in the coming days to decide whether or not I will take a position. (Not Financial Advice) T
TNXP (Request counter) Requested Analysis
Resistance at 3.02 and 4.75. Generally, I would not recommend this kind of chart and industry. The biotech industry tends to have a very volatile nature. It is usually driven by news/rumors. Extremely hard to predict. If you're lucky, you may get a 20-30% rally price due to some
$TNXP MACD OptimizerHuge move today after yesterdays MACD Signal from @KioseffTrading MACD Optimizer script.
Tonix Pharmaceuticals Announces Share Repurchase ProgramTNXP: Tonix Pharmaceuticals Holding Corp.
2022-05-31 16:05:00
Tonix Pharmaceuticals Announces Share Repurchase Program
TNXP Tonix Pharmaceuticals produces the Monkeypox Vaccine ! Tonix is a producer of the TNX-801 vaccine, effective against Smallpox and Monkeypox.
But that`s not all!
They have a strong balance sheet, Cash and Cash Equivalents Totaled Approximately $140 Million VS its mk cap of only $44.03Mil.
Seth Lederman, M.D., Chief Executive Officer of Tonix: “Tonix
TNXP Looking GoodDouble bottomd out, with it being in a downtrend for a long time, I expect a reversal to occur.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange TONIX PHA.NEW2024 DL-,001 stocks are traded under the ticker TPM.
We've gathered analysts' opinions on TONIX PHA.NEW2024 DL-,001 future price: according to them, TPM price has a max estimate of 44.47 EUR and a min estimate of 3.71 EUR. Watch TPM chart and read a more detailed TONIX PHA.NEW2024 DL-,001 stock forecast: see what analysts think of TONIX PHA.NEW2024 DL-,001 and suggest that you do with its stocks.
Yes, you can track TONIX PHA.NEW2024 DL-,001 financials in yearly and quarterly reports right on TradingView.
TONIX PHA.NEW2024 DL-,001 is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
TPM earnings for the last quarter are −18.00 EUR per share, whereas the estimation was −3.06 EUR resulting in a −489.00% surprise. The estimated earnings for the next quarter are −3.48 EUR per share. See more details about TONIX PHA.NEW2024 DL-,001 earnings.
TONIX PHA.NEW2024 DL-,001 revenue for the last quarter amounts to 2.06 M EUR, despite the estimated figure of 3.27 M EUR. In the next quarter, revenue is expected to reach 2.83 M EUR.
TPM net income for the last quarter is −73.55 M EUR, while the quarter before that showed −13.85 M EUR of net income which accounts for −431.20% change. Track more TONIX PHA.NEW2024 DL-,001 financial stats to get the full picture.
No, TPM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 11, 2024, the company has 103.00 employees. See our rating of the largest employees — is TONIX PHA.NEW2024 DL-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TONIX PHA.NEW2024 DL-,001 EBITDA is −84.31 M EUR, and current EBITDA margin is −1.47 K%. See more stats in TONIX PHA.NEW2024 DL-,001 financial statements.
Like other stocks, TPM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TONIX PHA.NEW2024 DL-,001 stock right from TradingView charts — choose your broker and connect to your account.